|
1
|
Schlageter M, Terracciano LM, D'Angelo S
and Sorrentino P: Histopathology of hepatocellular carcinoma. World
J Gastroenterol. 20:15955–15964. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gu W, Fang FF, Li B, Cheng BB and Ling CQ:
Characterization and resistance mechanisms of A 5-fluorouracil
resistance hepatocellular carcinoma cell line. Asian Pac J Cancer
Prev. 13:4807–4814. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Verheggen C, Almouzni G and
Hernandez-Verdun D: The ribosomal RNA processing machinery is
recruited to the nucleolar domain before RNA polymerase I during
Xenopus laevis development. J Cell Biol. 149:293–306. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Huang N, Negi S, Szebeni A and Olson MO:
Protein NPM3 interacts with the multifunctional nucleolar protein
B23/nucleophosmin and inhibits ribosome biogenesis. J Biol Chem.
280:5496–5502. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Okuda M, Horn HF, Tarapore P, Tokuyama Y,
Smulian AG, Chan PK, Knudsen ES, Hofmann IA, Snyder JD, Bove KE and
Fukasawa K: Nucleophosmin/B23 is a target of CDK2/cyclin E in
centrosome duplication. Cell. 103:127–140. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Okuda M: The role of nucleophosmin in
centrosome duplication. Oncogene. 21:6170–6174. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Grisendi S, Bernardi R, Rossi M, Cheng K,
Khandker L, Manova K and Pandolfi PP: Role of nucleophosmin in
embryonic development and tumorigenesis. Nature. 437:147–153. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hingorani K, Szebeni A and Olson MO:
Mapping the functional domains of nucleolar protein B23. J Biol
Chem. 275:24451–24457. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Szebeni A, Hingorani K, Negi S and Olson
MO: Role of protein kinase CK2 phosphorylation in the molecular
chaperone activity of nucleolar protein b23. J Biol Chem.
278:9107–9115. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Colombo E, Marine JC, Danovi D, Falini B
and Pelicci PG: Nucleophosmin regulates the stability and
transcriptional activity of p53. Nat Cell Biol. 4:529–533. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li J, Zhang X, Sejas DP, Bagby GC and Pang
Q: Hypoxia-induced nucleophosmin protects cell death through
inhibition of p53. J Biol Chem. 279:41275–41279. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Maiguel DA, Jones L, Chakravarty D, Yang C
and Carrier F: Nucleophosmin sets a threshold for p53 response to
UV radiation. Mol Cell Biol. 24:3703–3711. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Itahana K, Bhat KP, Jin A, Itahana Y,
Hawke D, Kobayashi R and Zhang Y: Tumor suppressor ARF degrades
B23, a nucleolar protein involved in ribosome biogenesis and cell
proliferation. Mol Cell. 12:1151–1164. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bertwistle D, Sugimoto M and Sherr CJ:
Physical and functional interactions of the Arf tumor suppressor
protein with nucleophosmin/B23. Mol Cell Biol. 24:985–996. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Brady SN, Yu Y, Maggi LB Jr and Weber JD:
ARF impedes NPM/B23 shuttling in an Mdm2-sensitive tumor suppressor
pathway. Mol Cell Biol. 24:9327–9338. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Feuerstein N and Mond JJ: ‘Numatrin,’ a
nuclear matrix protein associated with induction of proliferation
in B lymphocytes. J Biol Chem. 262:11389–11397. 1987.PubMed/NCBI
|
|
17
|
Feuerstein N, Spiegel S and Mond JJ: The
nuclear matrix protein, numatrin (B23), is associated with growth
factor-induced mitogenesis in Swiss 3T3 fibroblasts and with T
lymphocyte proliferation stimulated by lectins and anti-T cell
antigen receptor antibody. J Cell Biol. 107:1629–1642. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pulford K, Morris SW and Mason DY:
Anaplastic lymphoma kinase proteins and malignancy. Curr Opin
Hematol. 8:231–236. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tanaka M, Sasaki H, Kino I, Sugimura T and
Terada M: Genes preferentially expressed in embryo stomach are
predominantly expressed in gastric cancer. Cancer Res.
52:3372–3377. 1992.PubMed/NCBI
|
|
20
|
Nozawa Y, Van Belzen N, van der Made AC,
Dinjens WN and Bosman FT: Expression of nucleophosmin/B23 in normal
and neoplastic colorectal mucosa. J Pathol. 178:48–52. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tsui KH, Cheng AJ, Chang Pe, Pan TL and
Yung BY: Association of nucleophosmin/B23 mRNA expression with
clinical outcome in patients with bladder carcinoma. Urology.
64:839–844. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Subong EN, Shue MJ, Epstein JI, Briggman
JV, Chan PK and Partin AW: Monoclonal antibody to prostate cancer
nuclear matrix protein (PRO:4-216) recognizes nucleophosmin/B23.
Prostate. 39:298–304. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Onda M, Emi M, Yoshida A, Miyamoto S,
Akaishi J, Asaka S, Mizutani K, Shimizu K, Naqahama M, Ito K, et
al: Comprehensive gene expression profiling of anaplastic thyroid
cancer with cDNA microarray of 25 344 genes. Endocr Relat Cancer.
11:843–854. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang Y: The ARF-B23 connection:
implications for growth control and cancer treatment. Cell Cycle.
3:259–262. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Schnittger S, Schoch C, Kern W, Mecucci C,
Tschulik C, Martelli MF, Haferlach T, Hiddemann W and Falini B:
Nucleophosmin gene mutations are predictors of favorable prognosis
in acute myelogenous leukemia with a normal karyotype. Blood.
106:3733–3739. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gottesman MM, Fojo T and Bates SE:
Multidrug resistance in cancer: Role of ATP-dependent transports.
Nat Rev Cancer. 2:48–58. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ambudkar SV, Kimchi-Sarfaty C, Sauna ZE
and Gottesman MM: P-glycoprotein: From genomics to mechanism.
Oncogene. 22:7468–7485. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Glavinas H, Krajcsi P, Cserepes J and
Sarkadi B: The role of ABC transporters in drug resistance,
metabolism and toxicity. Curr Drug Deliv. 1:27–42. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Varma MV, Ashokraj Y, Dey CS and
Panchagnula R: P-glycoprotein inhibitors and their screening: A
perspective from bioavailability enhancement. Pharmacol Res.
48:347–359. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Johnson WW: P-glycoprotein-mediated efflux
as a major factor in the variance of absorption and distribution of
drugs: Modulation of chemotherapy resistance. Methods Find Exp Clin
Pharmacol. 24:501–514. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fojo T and Bates S: Strategies for
reversing drug resistance. Oncogene. 22:7512–7523. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Nguyen T, Zhang XD and Hersey P: Relative
resistance of fresh isolates of melanoma to tumor necrosis
factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis.
Clin Cancer Res. 7:966s–973s. 2001.PubMed/NCBI
|
|
33
|
Li X, Zhao H, Wu Y, Zhang S, Zhao X, Zhang
Y, Wang J, Wang J and Liu H: Up-regulation of hypoxia-inducible
factor-1α enhanced the cardioprotective effects of ischemic
postconditioning in hyperlipidemic rats. Acta Biochim Biophys Sin
(Shanghai). 46:112–118. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Minotti G, Menna P, Salvatorelli E, Cairo
G and Gianni L: Anthracyclines: Molecular advances and
pharmacologic developments in antitumor activity and
cardiotoxicity. Pharmacol Rev. 56:185–229. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Qi W, Shakalya K, Stejskal A, Goldman A,
Beeck S, Cooke L and Mahadevan D: NSC348884, a nucleophosmin
inhibitor disrupts oligomer formation and induces apoptosis in
human cancer cells. Oncogene. 2:4210–4220. 2008. View Article : Google Scholar
|
|
37
|
Pérez-Tomás R: Multidrug resistance:
Retrospect and prospects in anti-cancer drug treatment. Curr Med
Chem. 13:1859–1876. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Daniel C, Bell C, Burton C, Harguindey S,
Reshkin SJ and Rauch C: The role of proton dynamics in the
development and maintenance of multidrug resistance in cancer.
Biochim Biophys Acta. 1832:606–617. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yung BY: Oncogenic role of
nucleophosmin/B23. Chang Gung Med J. 30:285–293. 2007.PubMed/NCBI
|
|
40
|
Lam L, Aktary Z, Bishay M, Werkman C, Kuo
CY, Heacock M, Srivastava N, Mackey JR and Pasdar M: Regulation of
subcellular distribution and oncogenic potential of nucleophosmin
by plakoglobin. Oncogenesis. 1:e42012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Skaar TC, Prasad SC, Sharareh S, Lippman
ME, Brunner N and Clarke R: Two-dimensional gel electrophoresis
analyses identify nucleophosmin as an estrogen regulated protein
associated with acquired estrogen-independence in human breast
cancer cells. J Steroid Biochem Mol Biol. 67:391–402. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Grisendi S, Mecucci C, Falini B and
Pandolfi PP: Nucleophosmin and cancer. Nat Rav Cancer. 6:493–505.
2006. View Article : Google Scholar
|
|
43
|
Kikuta K, Tochigi N, Shimoda T, Yabe H,
Morioka H, Toyama Y, Hosono A, Beppu Y, Kawai A, Hirohashi S and
Kondo T: Nucleophosmin as a candidate prognostic biomarker of
Ewing's sarcoma revealed by proteomics. Clin Cancer Res.
15:2885–2894. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yang YX, Hu HD, Zhang DZ and Ren H:
Identification of proteins responsible for the development of
adriamycin resistance in human gastric cancer cells using
comparative proteomics analysis. J Biochem Mol Biol. 40:853–860.
2007.PubMed/NCBI
|
|
45
|
Wu MH, Chang JH, Chou CC and Yung BY:
Involvement of nucleophosmin-B23 in the response of HeLa cells to
UV irradiation. Int J Cancer. 97:297–305. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wu MH, Chang JH and Yung BY: Resistance to
UV-induced cell-killing in nucleophosmin/B23 over-expressed NIH3T3
fibroblasts: Enhancement of DNA repair and up-regulation of PCNA in
association with nucleophosmin/B23 over-expression. Carcinogenesis.
23:93–100. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Clarke R, Liu MC, Bouker KB, Gu Z, Lee RY,
Zhu Y, Skaar TC, Gomez B, O'Brien K, Wang Y, et al: Antiestrogen
resistance in breast cancer and the role of estrogen receptor
signaling. Oncogene. 22:7316–7339. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zhang L, Xiao R, Xiong J, Leng J, Ehtisham
A, Hu Y, Ding Q, Xu H, Liu S, Wang J, et al: Activated ERM Protein
plays a critical role in drug resistance of MOLT4 cells induced by
CCL25. PLoS One. 8:e523842013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Meszaros P, Hummel I, Klappe K, Draghiciu
O, Hoekstra D and Kok JW: The fuction of the ATP-bnding cassette
(ABC) transporter ABCB1 is not susceptible to actin disruption.
Biochim Biophys Acta. 1828:340–351. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Avendaño C and Menéndez JC: Inhibitors of
multidrug resistance to antitumor agents (MDR). Curr Med Chem.
9:159–193. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Leonard GD, Fojo T and Bates SE: The role
of ABC transporters in clinical practice. Oncologist. 8:411–424.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Tsuruo T: Molecular cancer therapeutics:
Recent progress and targets in drug resistance. Intern Med.
42:237–243. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ozben T: Mechanism and strategies to
overcome multiple drug resistance in cancer. FEBS Lett.
580:2903–2909. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Hu YP, Pourquer P, Doignon F, Crouzet M
and Robert J: Effects of modulators of multidrug resistance on the
expression of the MDR1 gene in human KB cells in culture.
Anticancer Drugs. 7:738–744. 1996. View Article : Google Scholar : PubMed/NCBI
|
